Hearing on "Examining the FDA’s Regulation of Over-the-Counter Monograph Drugs"
The Subcommittee on Health of the Committee on Energy and Commerce held a hearing on Tuesday, April 1, 2025, at 10:15 a.m. (EDT) in the John D. Dingell Room, 2123 Rayburn House Office Building. The hearing is entitled "Examining the FDA's Regulation of Over-the-Counter Monograph Drugs."
Key Documents
Opening Statement from Full Committee Ranking Member Pallone as prepared for delivery
Opening Statement from Subcommittee on Health Ranking Member DeGette as prepared for delivery
Livestream
Witnesses
Mr. Carl D'Ruiz, MPH
Senior Science, Advocacy, and Business Development Manager for Beauty and Care, North America
dsm-firmenich
Mr. Scott Faber
Senior Vice President
Government Affairs, Environmental Working Group
Mr. Kevin Menzel
Member, Board of Directors, Consumer Healthcare Products Association
President, Focus Consumer Healthcare
Mr. Douglas M. Troutman
Interim Co-Chief Executive Officer
American Cleaning Institute
Ms. Kim Wezik, MPH
Director of Advocacy
Melanoma Research Foundation